Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study.

Dimitrakopoulou VI, Tsilidis KK, Haycock PC, Dimou NL, Al-Dabhani K, Martin RM, Lewis SJ, Gunter MJ, Mondul A, Shui IM, Theodoratou E, Nimptsch K, Lindström S, Albanes D, Kühn T, Key TJ, Travis RC, Vimaleswaran KS; GECCO Consortium; PRACTICAL Consortium; GAME-ON Network (CORECT, DRIVE, ELLIPSE, FOCI-OCAC, TRICL-ILCCO), Kraft P, Pierce BL, Schildkraut JM.

BMJ. 2017 Oct 31;359:j4761. doi: 10.1136/bmj.j4761.

2.

Gene expression profiling of prostate tissue identifies chromatin regulation as a potential link between obesity and lethal prostate cancer.

Ebot EM, Gerke T, Labbé DP, Sinnott JA, Zadra G, Rider JR, Tyekucheva S, Wilson KM, Kelly RS, Shui IM, Loda M, Kantoff PW, Finn S, Vander Heiden MG, Brown M, Giovannucci EL, Mucci LA.

Cancer. 2017 Nov 1;123(21):4130-4138. doi: 10.1002/cncr.30831. Epub 2017 Jul 12.

PMID:
28700821
3.

Interactions Between Genome-Wide Significant Genetic Variants and Circulating Concentrations of 25-Hydroxyvitamin D in Relation to Prostate Cancer Risk in the National Cancer Institute BPC3.

Dimitrakopoulou VI, Travis RC, Shui IM, Mondul A, Albanes D, Virtamo J, Agudo A, Boeing H, Bueno-de-Mesquita HB, Gunter MJ, Johansson M, Khaw KT, Overvad K, Palli D, Trichopoulou A, Giovannucci E, Hunter DJ, Lindström S, Willett W, Gaziano JM, Stampfer M, Berg C, Berndt SI, Black A, Hoover RN, Kraft P, Key TJ, Tsilidis KK.

Am J Epidemiol. 2017 Mar 15;185(6):452-464. doi: 10.1093/aje/kww143.

4.

Prostate tumor DNA methylation is associated with cigarette smoking and adverse prostate cancer outcomes.

Shui IM, Wong CJ, Zhao S, Kolb S, Ebot EM, Geybels MS, Rubicz R, Wright JL, Lin DW, Klotzle B, Bibikova M, Fan JB, Ostrander EA, Feng Z, Stanford JL.

Cancer. 2016 Jul 15;122(14):2168-77. doi: 10.1002/cncr.30045. Epub 2016 May 3.

5.

Calcium-Sensing Receptor Tumor Expression and Lethal Prostate Cancer Progression.

Ahearn TU, Tchrakian N, Wilson KM, Lis R, Nuttall E, Sesso HD, Loda M, Giovannucci E, Mucci LA, Finn S, Shui IM.

J Clin Endocrinol Metab. 2016 Jun;101(6):2520-7. doi: 10.1210/jc.2016-1082. Epub 2016 Apr 26.

6.

Association of Prostate Cancer Risk Variants with TMPRSS2:ERG Status: Evidence for Distinct Molecular Subtypes.

Penney KL, Pettersson A, Shui IM, Graff RE, Kraft P, Lis RT, Sesso HD, Loda M, Mucci LA.

Cancer Epidemiol Biomarkers Prev. 2016 May;25(5):745-9. doi: 10.1158/1055-9965.EPI-15-1078. Epub 2016 Mar 3.

7.

Trichomonas vaginalis infection and risk of advanced prostate cancer.

Shui IM, Kolb S, Hanson C, Sutcliffe S, Rider JR, Stanford JL.

Prostate. 2016 May;76(7):620-3. doi: 10.1002/pros.23153. Epub 2016 Jan 28.

8.

Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors.

Geybels MS, Alumkal JJ, Luedeke M, Rinckleb A, Zhao S, Shui IM, Bibikova M, Klotzle B, van den Brandt PA, Ostrander EA, Fan JB, Feng Z, Maier C, Stanford JL.

Clin Epigenetics. 2015 Dec 12;7:128. doi: 10.1186/s13148-015-0161-6. eCollection 2015.

9.

Plasma vitamin D biomarkers and leukocyte telomere length in men.

Julin B, Shui IM, Prescott J, Giovannucci EL, De Vivo I.

Eur J Nutr. 2017 Mar;56(2):501-508. doi: 10.1007/s00394-015-1095-7. Epub 2015 Nov 11.

10.

Calcium intake, polymorphisms of the calcium-sensing receptor, and recurrent/aggressive prostate cancer.

Binder M, Shui IM, Wilson KM, Penney KL; PRACTICAL/ELLIPSE Consortium, Mucci LA, Kibel AS.

Cancer Causes Control. 2015 Dec;26(12):1751-9. doi: 10.1007/s10552-015-0668-3. Epub 2015 Sep 25.

11.

ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3).

Markt SC, Shui IM, Unger RH, Urun Y, Berg CD, Black A, Brennan P, Bueno-de-Mesquita HB, Gapstur SM, Giovannucci E, Haiman C, Henderson B, Hoover RN, Hunter DJ, Key TJ, Khaw KT, Canzian F, Larranga N, Le Marchand L, Ma J, Naccarati A, Siddiq A, Stampfer MJ, Stattin P, Stevens VL, Stram DO, Tjønneland A, Travis RC, Trichopoulos D, Ziegler RG, Lindstrom S, Kraft P, Mucci LA, Choueiri TK, Wilson KM.

Prostate. 2015 Nov;75(15):1677-81. doi: 10.1002/pros.23035. Epub 2015 Aug 13.

12.

No Association of ApoE Genotype with Risk of Prostate Cancer: A Nested Case-Control Study.

Liu H, Shui IM, Platz EA, Mucci LA, Giovannucci EL.

Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1632-4. doi: 10.1158/1055-9965.EPI-15-0367. Epub 2015 Jul 19.

13.

Reply to investigating the relationship between vitamin d and cancer requires dosing the bioavailable nonhydroxylated vitamin d storage in cancer tissues.

Shui IM, Giovannucci E.

Cancer. 2015 Sep 15;121(18):3363-4. doi: 10.1002/cncr.29450. Epub 2015 May 19. No abstract available.

14.

Circulating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.

Shui IM, Mondul AM, Lindström S, Tsilidis KK, Travis RC, Gerke T, Albanes D, Mucci LA, Giovannucci E, Kraft P; Breast and Prostate Cancer Cohort Consortium Group.

Cancer. 2015 Jun 15;121(12):1949-56. doi: 10.1002/cncr.29320. Epub 2015 Mar 2.

15.

Vitamin D-associated genetic variation and risk of breast cancer in the breast and prostate cancer cohort consortium (BPC3).

Mondul AM, Shui IM, Yu K, Weinstein SJ, Tsilidis KK, Joshi AD, Agudo A, Berg CD, Black A, Buring JE, Chasman DI, Gaudet MM, Haiman C, Hankinson SE, Henderson BE, Hoover RN, Hunter DJ, Khaw KT, Kühn T, Kvaskoff M, Le Marchand L, Lindström S, McCullough ML, Overvad K, Peeters PH, Riboli E, Ridker PM, Stram DO, Sund M, Trichopoulos D, Tumino R, Weiderpass E, Willett W, Kraft P, Ziegler RG, Albanes D.

Cancer Epidemiol Biomarkers Prev. 2015 Mar;24(3):627-30. doi: 10.1158/1055-9965.EPI-14-1127. Epub 2014 Dec 26.

16.

Calcium and phosphorus intake and prostate cancer risk: a 24-y follow-up study.

Wilson KM, Shui IM, Mucci LA, Giovannucci E.

Am J Clin Nutr. 2015 Jan;101(1):173-83. doi: 10.3945/ajcn.114.088716. Epub 2014 Nov 19.

17.

Circadian clock genes and risk of fatal prostate cancer.

Markt SC, Valdimarsdottir UA, Shui IM, Sigurdardottir LG, Rider JR, Tamimi RM, Batista JL, Haneuse S, Flynn-Evans E, Lockley SW, Czeisler CA, Stampfer MJ, Launer L, Harris T, Smith AV, Gudnason V, Lindstrom S, Kraft P, Mucci LA.

Cancer Causes Control. 2015 Jan;26(1):25-33. doi: 10.1007/s10552-014-0478-z. Epub 2014 Nov 12.

18.

Association of prostate cancer risk variants with gene expression in normal and tumor tissue.

Penney KL, Sinnott JA, Tyekucheva S, Gerke T, Shui IM, Kraft P, Sesso HD, Freedman ML, Loda M, Mucci LA, Stampfer MJ.

Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):255-60. doi: 10.1158/1055-9965.EPI-14-0694-T. Epub 2014 Nov 4.

19.

Polymorphisms of an innate immune gene, toll-like receptor 4, and aggressive prostate cancer risk: a systematic review and meta-analysis.

Weng PH, Huang YL, Page JH, Chen JH, Xu J, Koutros S, Berndt S, Chanock S, Yeager M, Witte JS, Eeles RA, Easton DF, Neal DE, Donovan J, Hamdy FC, Muir KR, Giles G, Severi G, Smith JR, Balistreri CR, Shui IM, Chen YC.

PLoS One. 2014 Oct 31;9(10):e110569. doi: 10.1371/journal.pone.0110569. eCollection 2014. Review.

20.

Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancer.

Cao Y, Nimptsch K, Shui IM, Platz EA, Wu K, Pollak MN, Kenfield SA, Stampfer MJ, Giovannucci EL.

Int J Cancer. 2015 May 15;136(10):2418-26. doi: 10.1002/ijc.29295. Epub 2014 Nov 10.

21.

The expanding role of body mass in active surveillance for prostate cancer.

Ahearn TU, Shui IM, Giovannucci EL.

Eur Urol. 2014 Nov;66(5):849-50. doi: 10.1016/j.eururo.2014.06.043. Epub 2014 Jul 15. No abstract available.

PMID:
25037639
22.

Genetic polymorphisms of the glycine N-methyltransferase and prostate cancer risk in the health professionals follow-up study.

Chen M, Huang YL, Huang YC, Shui IM, Giovannucci E, Chen YC, Chen YM.

PLoS One. 2014 May 6;9(5):e94683. doi: 10.1371/journal.pone.0094683. eCollection 2014.

23.

Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.

Shui IM, Lindström S, Kibel AS, Berndt SI, Campa D, Gerke T, Penney KL, Albanes D, Berg C, Bueno-de-Mesquita HB, Chanock S, Crawford ED, Diver WR, Gapstur SM, Gaziano JM, Giles GG, Henderson B, Hoover R, Johansson M, Le Marchand L, Ma J, Navarro C, Overvad K, Schumacher FR, Severi G, Siddiq A, Stampfer M, Stevens VL, Travis RC, Trichopoulos D, Vineis P, Mucci LA, Yeager M, Giovannucci E, Kraft P.

Eur Urol. 2014 Jun;65(6):1069-75. doi: 10.1016/j.eururo.2013.12.058. Epub 2014 Jan 4.

24.

A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer.

Schoenfeld JD, Margalit DN, Kasperzyk JL, Shui IM, Rider JR, Epstein MM, Meisner A, Kenfield SA, Martin NE, Nguyen PL, Kantoff PW, Giovannucci EL, Stampfer MJ, Mucci LA.

Clin Cancer Res. 2013 Mar 15;19(6):1612-9. doi: 10.1158/1078-0432.CCR-12-2718. Epub 2013 Feb 4.

25.

Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium.

Mondul AM, Shui IM, Yu K, Travis RC, Stevens VL, Campa D, Schumacher FR, Ziegler RG, Bueno-de-Mesquita HB, Berndt S, Crawford ED, Gapstur SM, Gaziano JM, Giovannucci E, Haiman CA, Henderson BE, Hunter DJ, Johansson M, Key TJ, Le Marchand L, Lindström S, McCullough ML, Navarro C, Overvad K, Palli D, Purdue M, Stampfer MJ, Weinstein SJ, Willett WC, Yeager M, Chanock SJ, Trichopoulos D, Kolonel LN, Kraft P, Albanes D.

Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):688-96. doi: 10.1158/1055-9965.EPI-13-0007-T. Epub 2013 Feb 1.

26.

Prediagnostic circulating sex hormones are not associated with mortality for men with prostate cancer.

Gershman B, Shui IM, Stampfer M, Platz EA, Gann PH, Sesso HL, DuPre N, Giovannucci E, Mucci LA.

Eur Urol. 2014 Apr;65(4):683-9. doi: 10.1016/j.eururo.2013.01.003. Epub 2013 Jan 11.

27.

Common genetic variation of the calcium-sensing receptor and lethal prostate cancer risk.

Shui IM, Mucci LA, Wilson KM, Kraft P, Penney KL, Stampfer MJ, Giovannucci E.

Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):118-26. doi: 10.1158/1055-9965.EPI-12-0670-T. Epub 2012 Nov 2.

28.

Guillain-Barré syndrome incidence in a large United States cohort (2000-2009).

Shui IM, Rett MD, Weintraub E, Marcy M, Amato AA, Sheikh SI, Ho D, Lee GM, Yih WK; Vaccine Safety Datalink Research Team.

Neuroepidemiology. 2012;39(2):109-15. doi: 10.1159/000339248. Epub 2012 Jul 28.

PMID:
22846726
29.

Seasonal variation in expression of markers in the vitamin D pathway in prostate tissue.

Epstein MM, Andrén O, Kasperzyk JL, Shui IM, Penney KL, Fall K, Rider JR, Stampfer MJ, Andersson SO, Giovannucci E, Mucci LA.

Cancer Causes Control. 2012 Aug;23(8):1359-66. doi: 10.1007/s10552-012-0016-9. Epub 2012 Jun 19.

30.

Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study.

Shui IM, Mucci LA, Kraft P, Tamimi RM, Lindstrom S, Penney KL, Nimptsch K, Hollis BW, Dupre N, Platz EA, Stampfer MJ, Giovannucci E.

J Natl Cancer Inst. 2012 May 2;104(9):690-9. doi: 10.1093/jnci/djs189. Epub 2012 Apr 12.

31.

Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants.

Shui IM, Baggs J, Patel M, Parashar UD, Rett M, Belongia EA, Hambidge SJ, Glanz JM, Klein NP, Weintraub E.

JAMA. 2012 Feb 8;307(6):598-604. doi: 10.1001/jama.2012.97.

PMID:
22318281
32.

Genetic variation in the toll-like receptor 4 and prostate cancer incidence and mortality.

Shui IM, Stark JR, Penney KL, Schumacher FR, Epstein MM, Pitt MJ, Stampfer MJ, Tamimi RM, Lindstrom S, Sesso HD, Fall K, Ma J, Kraft P, Giovannucci E, Mucci LA.

Prostate. 2012 Feb 1;72(2):209-16. doi: 10.1002/pros.21423. Epub 2011 May 11.

33.

Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project.

Yih WK, Kulldorff M, Fireman BH, Shui IM, Lewis EM, Klein NP, Baggs J, Weintraub ES, Belongia EA, Naleway A, Gee J, Platt R, Lieu TA.

Pediatrics. 2011 May;127 Suppl 1:S54-64. doi: 10.1542/peds.2010-1722I. Epub 2011 Apr 18.

PMID:
21502252
34.

Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine.

Belongia EA, Irving SA, Shui IM, Kulldorff M, Lewis E, Yin R, Lieu TA, Weintraub E, Yih WK, Li R, Baggs J; Vaccine Safety Datalink Investigation Group.

Pediatr Infect Dis J. 2010 Jan;29(1):1-5. doi: 10.1097/INF.0b013e3181af8605.

PMID:
19907356
35.

Predictive value of seizure ICD-9 codes for vaccine safety research.

Shui IM, Shi P, Dutta-Linn MM, Weintraub ES, Hambidge SJ, Nordin JD, Lieu TA; Vaccine Safety Datalink Research Team.

Vaccine. 2009 Aug 27;27(39):5307-12. doi: 10.1016/j.vaccine.2009.06.092. Epub 2009 Jul 17.

PMID:
19616500
36.

Parents concerned about vaccine safety: Differences in race/ethnicity and attitudes.

Shui IM, Weintraub ES, Gust DA.

Am J Prev Med. 2006 Sep;31(3):244-51. Epub 2006 Jul 13.

PMID:
16905036

Supplemental Content

Loading ...
Support Center